Abstract. TRAIL is a TNF family member that engages apoptosis via recruitment and rapid activation of caspase-8. Oxygen-free radicals, more generally known as reactive oxygen species (ROS) are well recognized for playing an important role in the regulation of tumor cell apoptosis. ROS within the cells act as secondary messengers in intracellular signalling cascades therefore function as anti-tumorigenic species. But very little is known about the effect of ROS on TRAIL-induced apoptosis. In this study we investigated the effect of CCCP, a classic uncoupler of oxidative phosphorylation, on TRAIL-induced apoptosis in TRAIL-resistant MCF-7 cells. It was found that pretreatment with CCCP for 6 h and then treatment with TRAIL for additional 3 h markedly enhanced apoptosis by 2-fold as compared with TRAIL alone. The uncoupling effect enhanced TRAIL-induced apoptosis by ROS generation. Moreover, CCCP treatment also reduced mitochondrial transmembrane potential (MTP, ΔΨm) and induced Bax translocation to the mitochondria of its own account. This sensitization was inhibited with N-acetyl-L-cysteine (NAC) treatment by abrogating the ROS which was generated by the combined treatment of CCCP and TRAIL. Of interest, NAC also inhibited reduction of the ΔΨm and Bax translocation after CCCP pretreatment which suggest that the generartion of ROS may precede the loss in MTP. Thus, we demonstrated that CCCP-induced ROS generation enhanced TRAIL induced apoptosis by regulation of Bax translocation and mitochondrial transmembrane potential. The enhancing effect by CCCP-induced ROS generation was restored after NAC treatment. Therefore, our results suggest that uncoupling the cells by CCCP can overcome the resistance to TRAIL protein and can be a very efficient treatment for the tumor cells especially resistant to TRAIL-induced apoptosis.
Introduction
Apoptosis is a tightly regulated cell death program that plays a pivotal role in a variety of biological processes. Unlike necrosis, apoptosis is a fundamental biochemical process involving the selective and controlled elimination of cells in multicellular organisms during normal cellular differentiation and development (1) (2) (3) . Apoptosis is characterised by membrane blebbing, nuclear fragmentation, formation of apoptosomes and also involved in tissue homeostasis, aging, various pathological processes and irreversible cell injury (4, 5) . The regulation of apoptosis occurs through extrinsic and intrinsic pathways the extrinsic pathway is engaged through so-called death receptors at the cell surface (6) (7) (8) . A misregulation or failure of apoptosis can result in the development of cancer and the resistance to antitumor treatment might be due to insensitivity to the induction of apoptosis. Therefore, apoptosis is a mechanism that needs to be exploited when developing new chemotherapies for cancer.
Carbonyl cyanide m-chlorophenylhydrazone (CCCP) is a protonophore that renders the mitochondrial inner membrane permeable for protons and causes dissipation of the proton gradient across the inner mitochondrial membrane. CCCP also causes uncoupling of mitochondria so that the transfer of electrons through the electron transfer chain is no longer linked to the adenosine triphosphate (ATP) production, due to the loss of the electrochemical gradient. CCCP-induced apoptosis has been reported in many cell lines such as Jurkatneo, FL5.12, HL-60, and ST486 (9) (10) (11) (12) . However, some studies have reported that CCCP alone does not induce apoptosis (13) (14) (15) .
TRAIL is a recently identified member of the TNF family that also activates the cognate receptor molecules through trimerization in a similar manner to other TNF family members (16, 17) . DR4/TRAIL-R1 and DR5/TRAIL-R2 are intact TRAIL-Rs through which various apoptotic signals are transmitted into the cytoplasm. In contrast, DcR1 and DcR2 are truncated TRAIL-Rs with a deletion of the cytoplasmic regions containing the death domains. TRAIL has a unique selectivity for triggering apoptosis in tumor cells by engaging apoptosis via recruitment and rapid activation of caspase-8 and might be less active against normal cells. However, the role of ROS in TRAIL-induced apoptosis is yet to be clearly defined. Recent preclinical studies have demonstrated that the repeated systemic administration of the recombinant TRAIL protein effectively limited tumor growth without any serious side effects (18, 19) . As a result, TRAIL has attracted considerable attention as a promising treatment for human cancer.
Mitochondria play an important role in the intrinsic pathway of apoptosis. A number of changes occur in mitochondria following apoptotic signals such as loss of mitochondrial transmembrane potential (MTP, ΔΨm), generation of reactive oxygen species (ROS), opening of the permeability transition (PT) pore and release of apoptotic factors into the cytosol (20, 21) . ROS are known to play a dual role in biological systems, since they can be either harmful or beneficial to living systems. Present study investigated the effect of mitochondrial uncoupling on TRAIL-induced apoptosis in TRAIL-resistant MCF-7 cell line.
Materials and methods
Cell culture and reagents. MCF-7 (human breast adenocarcinoma) cells were obtained from the ATCC (The Global Bioresource Center) and were maintained in RPMI-1640 (Gibco BRL, USA) culture medium supplemented with 10% (v/v) fetal bovine serum and antibiotics (100 μg/ml penicillinstreptomycin). The cell cultures were incubated in an atmosphere containing 5% CO 2 at 37˚C. Carbonyl cyanide m-chlorophenylhydrazone (CCCP, Sigma) was dissolved in dimethylsulfoxide (DMSO) at a concentration of 20 mM and was used at a final concentration of 5-80 μM. N-acetyl-Lcysteine (NAC) was purchased from Sigma Chemicals Co. (St. Louis, MO, USA). 2',7'-Dichlorofluorescin diacetate and 5,5',6,6'-tetrachlo-1,1'3,3'-tetraethylbenzimidazol-carbocyanine iodide (JC-1) were purchased from Molecular Probes (Eugene, OR, USA).
Cell viability test. MCF-7 cells were plated at 1.0x10 4 cells in a 12-well plate, and incubated at 37˚C for 24 h. The cells were pretreated with different doses (0, 5, 10, 20, 40 and 80 μM) of carbonyl cyanide m-chlorophenylhydrazone (CCCP, Sigma) for 6 h and subsequently treated with TRAIL protein for 3 h. Cells were also pretreated with an anti-oxidant NAC (1 mM) for 1 h then followed by CCCP (20 μM) for 6 h and TRAIL for additional 3 h. The cell morphology was photographed under an optical microscope, and the cell viability was determined using the crystal violet staining method as described elsewhere (22) . Briefly, the cells were stained with a staining solution (0.5% crystal violet in 30% ethanol and 3% formaldehyde) for 10 min at room temperature, washed four times with water, and dried. Then the cells were lysed with a 1% SDS solution, and measured at 550 nm. The cell viability was calculated from the relative dye intensity and compared with the controls.
Evaluation of mitochondrial transmembrane potential (MTP).
The level of mitochondrial energization was determined using a lipophilic cation, 5,5',6,6'-tetrachlo-1,1'3,3'-tetraethylbenzimidazol-carbocyanine iodide (JC-1, Molecular Probes). This method is based on the ability of the fluorescent probe to enter the mitochondria selectively and reversibly change its color from green to orange as the mitochondrial potential increases. JC-1 exists as a monomer at low MTP values and shows a green fluorescence, while it forms an aggregate at a high MTP and shows a red fluorescence. Briefly, the cells were treated with NAC, CCCP and TRAIL for the indicated times, the cells were collected by centri-fugation, washed twice with a PBS buffer and resuspended in 500 μl PBS containing JC-1 at a concentration of 10 μM. After 30 min incubation at 37˚C, the cells were photographed using a fluoroscope and the red fluorescence was monitored with a fluorescence plate reader (SpectraMax fluorometer with SoftMax Programme, Molecular Probes, USA) at 490 and 590 nm as excitation and emission wavelengths, respectively.
Determination of reactive oxygen species. 2',7'-Dichlorofluorescin diacetate (DCFH-DA), a non-fluorescent probe that turns to highly fluorescent 2',7'-dichlorofluorescin on reaction with ROS was used to monitor the production of ROS. Briefly, after the treatment, media were collected in a 96-well microplate and diluted DCFH-DA at a concentration of 10 μM was added to each well. After 30 min incubation at 37˚C, DCFH fluorescence was determined with a fluorescence plate reader (SpectraMax fluorometer with SoftMax Programme, Molecular Probes, USA) at 490 and 525 nm as excitation and emission wavelengths, respectively.
Western blot assay. The whole cell lysates were prepared by harvesting the MCF-7 cells, washing them in cold phosphatebuffered saline, resuspending them in a lysis buffer [25 mM HEPES (pH 7.4), 100 mM EDTA, 5 mM MgCl 2 , 0.1 mM DTT, and protease inhibitor mixture] and sonicating the lysate. The proteins (30 μg) were separated on a 12-15% SDS gel and transferred to a nitrocellulose membrane. After incubation for 1 h with a 1:1000 primary antibody dilution buffer (1% milk with PBS-Tween), the membranes were developed by enhanced chemiluminescence using a secondary antibody dilution. Bax protein was probed using the antibody obtained from BD Pharmingen (San Diego, CA).
Cellular fractionation. MCF-7 cells were resuspended in mitochondrial buffer (210 mM sucrose, 70 mM mannitol, 1 mM EDTA, 10 mM HEPES), broken by six passages through a 25-guage needle and subjected to centrifugation at 700 g to pellet nuclei. The post nuclear supernatant was centrifuged at 10000 g for 30 min to pellet the mitochondrial enriched heavy membrane fraction and the supernatant was used as cytosolic fraction. Total proteins were subjected to Western blot analysis.
Results

MCF-7 cells are sensitized to TRAIL-induced apoptosis by uncoupler of oxidative phosphorylation in dose-dependent manner.
To investigate the effects of uncoupling mitochondrial respiration on tumor cell response to TRAIL, we analysed the effects of CCCP, as a classic uncoupler of oxidative phosphorylation on TRAIL-induced apoptosis in MCF-7 cells. The cells were pretreated with indicated doses of CCCP for 6 h, and then treated with TRAIL protein for additional 3 h. As shown in Fig. 1 , CCCP enhanced TRAIL-induced apoptosis in a dose-dependent manner. MCF-7 cells were found to be resistant to TRAIL protein but CCCP markedly enhanced TRAIL-induced apoptosis at different concentrations (Fig. 1A) . The cell morphology also supported this enhanced effect of CCCP, showing that a CCCP pretreatment at all doses increased the number of apoptotic cells compared with that of CCCP and TRAIL alone (Fig. 1B) . Thus, mitochondrial uncoupling sensitized TRAIL-resistant MCF-7 cells to TRAIL-induced apoptosis.
CCCP-induced ROS generation enhanced TRAIL-induced apoptosis in MCF-7 cells.
To examine the role of ROS generation in TRAIL induced apoptosis, MCF-7 cells were treated with NAC before CCCP treatment and subsequently treated with TRAIL protein. Fig. 2A , clearly shows that NAC inhibited the enhanced effect of CCCP on TRAIL induced apoptosis. CCCP enhanced TRAIL effect and reduced the cell viability by 70% as compared to that of the negative control while NAC restored the cell viability to 70% (Fig. 2A) . The generation of ROS was examined by using 2',7'-dichlorofluorescin fluorescence as described in Materials and methods. CCCP and CCCP with the TRAIL induced ROS generation compared to control and TRAIL alone (Fig. 2B) . As expected, NAC pretreatment blocked the ROS generation in the cells pretreated with CCCP and then TRAIL and also prevented the enhanced effect of CCCP on TRAIL-induced apoptosis by restoring cell viability.
CCCP pretreatment induced loss in mitochondrial transmembrane potential (ΔΨm).
We investigated the effect of CCCP on mitochondrial transmembrane potential. MCF-7 cells were pretreated with CCCP for 2 h followed by TRAIL protein for 2 h. Photomicrographs indicate that CCCP and CCCP with TRAIL caused significant dissipation of ΔΨm as compared with that of the negative control and TRAIL alone (Fig. 3) . The fluoroscopic results presented in were pretreated with CCCP (20 μM/ml) for 6 h, and then coincubated with or without recombinant TRAIL protein (300 ng/ml) for an additional 2 h. NAC (1 mM) was added 1 h before CCCP treatment. Cell viability was determined by crystal violet staining method. Viability of control cells was set at 100%, and viability relative to the control is presented. The experiments were performed at triplicate, at least twice. (B) MCF-7 cells were pretreated with CCCP (20 μM/ ml) for 2 h, and then coincubated with or without recombinant TRAIL protein (300 ng/ml) for additional 2 h. ROS generation was measured in media by using a fluorescent dye 2',7'-dichlorofluorescin diacetate (10 μM). After incubation for 30 min, ROS level was measured using a spectrophotometer.
dissipation of ΔΨm induced by CCCP alone (data not shown).
The fluorescence values clearly indicate that the cells treated with CCCP and CCCP with TRAIL showed low red fluorescence as compared with TRAIL and negative control (Fig. 3B) . However, treatment with NAC followed by CCCP with TRAIL showed higher red fluorescence values than that of CCCP with TRAIL treatment. Overall, combine treatment of CCCP and TRAIL reduced ΔΨm in MCF-7 cells, which was restored after NAC treatment.
Anti-oxidant N-acetyl-L-cysteine (NAC) prevents Bax translocation.
MCF-7 cells were found to be resistant to TRAILinduced apoptosis even at high concentration (300 ng) but CCCP significantly enhanced TRAIL activity at different doses. Therefore, in order to investigate the apoptotic proteins involved, cytosolic and mitochondrial fractions were examined for Bax protein expression. After the treatment time with NAC, CCCP and TRAIL, cytosolic and mitochondrial fractions were prepared as indicated in Material and methods and subjected to Western blot analysis. As shown in Fig. 4A , CCCP translocated Bax protein from cytosol to mitochondria and the translocation of Bax protein was inhibited by NAC treatment. We also examined the expression of total Bax protein (Fig. 4B) . The combined treatment of CCCP and TRAIL enhanced Bax protein expression and NAC also abrogated the activation of Bax protein thus corresponding with the results of ROS generation and ΔΨm.
Discussion
The role of dissipation of ΔΨm and ROS generation in TRAILinduced apoptosis is yet to be clearly defined. In this study, we (23) and SKW6 cells (15) while induced apoptosis in Jukat-neo, FL5.12 (9) . In the present study, although CCCP alone reduced ΔΨm and induced ROS generation it did not induce apoptosis of its own account.
Previous studies have reported that uncoupling the mitochondrial respiration with CCCP enhanced the effect of various chemotherapeutic drugs. Exposure of CCCP-treated human osteosarcoma cells to staurosporine or etoposide resulted in rapid cell death accompanied by cytochrome c release and Bax association (23) . Moreover, CCCP was found to enhance the apoptosis-inducing ability of Fas/APO-1/CD95 signaling in Jurkat and CEM cells without causing apoptotic changes of its own account (15) . But there are very few reports on the effect of CCCP on TRAIL-induced apoptosis. It has been suggested that uncoupling the mitochondrial respiration sensitize the leukemic cells to TRAIL-induced apoptosis (13) . Also, human colon carcinoma cells were sensitized to TRAIL-induced apoptosis after CCCP pretreatment (14) .
We investigated the effect of CCCP pretreatment on TRAIL-induced apoptosis in MCF-7 cells. CCCP alone and in combination with TRAIL caused the dissipation of ΔΨm and ROS generation. In human colon carcinoma cells, the combined treatment of CCCP and TRAIL abrogated the ROS production by the complete loss of ΔΨm (14) . But here we found that CCCP treatment with TRAIL enhanced ROS generation by reducing ΔΨm in MCF-7 cells.
N-acetyl-l-cysteine (NAC) is an anti-oxidant drug and mainly known as a ROS scavenger. It reduces ROS generation and protects the cells from oxidative stress. Enhanced effect of CCCP on TRAIL-induced apoptosis was accompanied by dissipation of ΔΨm and ROS generation. It has been reported that arsenic trioxide-induced loss of ΔΨm was inhibited by NAC treatment (24) and in this study, CCCP induced loss in ΔΨm and ROS generation that sensitized MCF-7 cells to TRAIL-induced apoptosis. We used NAC as an anti-oxidant to investigate the role of ΔΨm and ROS generation. NAC treatment not only reduced ROS generation but also restored loss in ΔΨm. This study also found that NAC treatment restored the dissipation of ΔΨm in MCF-7 cells when treated with CCCP and TRAIL together. All together, this indicates that besides scavenging the ROS, NAC also inhibited dissipation of ΔΨm and thereby reduced enhanced effect of CCCP on TRAIL-induced apoptosis in MCF-7 cell line.
CCCP alone did not induce translocation of Bax protein in human osteosarcoma cells (23) . Our results demonstrate that CCCP treatment translocated Bax protein from cytosol to mitochondria in MCF-7 cells. There are different reports for CCCP-induced apoptosis in a variety of cell lines (9) (10) (11) (12) . The present study showed that CCCP did not induce apoptosis of its own account because of expression of antiapoptotic proteins such as Bcl-2 and IAP-2 (data not shown). Collectively, our data suggest that CCCP pretreatment enhanced TRAIL effect by lowering ΔΨm and ROS generation and thereby translocates Bax protein in MCF-7 cells.
In conclusion, ROS generation enhanced TRAIL-induced apoptosis in MCF-7 cells after CCCP treatment via Bax translocation. In addition, CCCP-induced ROS generation regulates the loss in MTP and Bax translocation. Thus, the combined treatment of CCCP and TRAIL might be useful in cancer therapy, particularly in TRAIL resistant cells. And therefore CCCP can be considered as a successful chemotherapeutic agent for ligand tumor therapy using TRAIL.
